Achieve Life Sciences Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +9.4% | -23.0% | +50.0% | +0.0% | -9.9% | +0.4% | -2.0% | -5.6% | -3.4% | +0.4% | -0.4% | |
| – | -39.7% | -29.2% | -78.9% | +145.4% | +40.6% | +7.1% | +70.1% | +49.5% | +5.2% | +54.8% | +64.5% | |
| – | – | +126.9% | +358.6% | -81.0% | +40.6% | +7.1% | +73.3% | +46.8% | – | – | – | |
| – | -39.3% | -252.6% | – | – | -129.4% | – | – | -93.6% | -1,084.8% | – | -276.9% | |
| – | +352.4% | -87.6% | +0.0% | +0.0% | +15.2% | -67.9% | +0.0% | -100.0% | – | -100.0% | – | |
| – | -138.7% | – | +19.2% | -140.5% | – | -100.3% | +0.0% | – | – | +102,661.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.9% | -100.0% | – | – | -66.3% | +554.8% | – | – | +63,729.8% | -100.0% | – | |
| – | +25.8% | -95.9% | +1,194.7% | +668.7% | +0.0% | +0.0% | +0.0% | -100.1% | -100.0% | – | – | |
| – | -30.3% | -100.0% | – | +887.4% | -12.3% | +88.6% | +12.0% | -47.2% | -20.9% | +217.6% | +6.2% | |
| – | -51.8% | -397.5% | – | -27.6% | +78.3% | +168.4% | -62.6% | -354.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.